Vivimed Labs Ltd Quarterly Results

Gross Sales

25.61

36.51

24.77

29.37

38.62

Excise Duty

0

0

0

0

0

Net Sales

25.61

36.51

24.77

29.37

38.62

Other Operating Income

0

0

0

0

0

Other Income

4.22

0.07

0.03

0.06

7.63

Total Income

29.83

36.58

24.8

29.43

46.24

Total Expenditure

28.08

35.45

25.41

40.37

67.09

PBIDT

1.75

1.12

-0.61

-10.94

-20.85

Interest

1.74

0.48

0.43

0.3

-33.33

PBDT

0.01

0.64

-1.04

-11.24

12.49

Depreciation

5.5

6.62

4.1

4.01

5.84

Minority Interest Before NP

0

0

0

0

0

Tax

0.23

0

0

0

0.02

Deferred Tax

-0.11

0

0

0

1.37

Reported Profit After Tax

-5.6

-5.98

-5.14

-15.25

5.26

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-5.6

-5.98

-5.14

-15.25

5.26

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

-5.6

-5.98

-5.14

-15.25

5.26

EPS (Unit Curr.)

-0.68

-0.72

-0.62

-1.84

0.63

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

16.58

16.58

16.58

16.58

16.58

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

6.83

3.06

-2.46

-37.24

-53.98

PBDTM(%)

0.03

1.75

-4.19

-38.27

32.34

PATM(%)

-21.86

-16.37

-20.75

-51.92

13.61